share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Kelly James Patrick

Novavax | 4: Statement of changes in beneficial ownership of securities

诺瓦瓦克斯医药 | 4：持股变动声明
美股sec公告 ·  03/26 19:05
Moomoo AI 已提取核心信息
James Patrick Kelly, the Executive Vice President, Chief Financial Officer, and Treasurer of Novavax, Inc. (NVAX), has executed a transaction involving the company's stock. The action took place on March 1, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Kelly after the transaction was not provided. This information is typically crucial for investors to assess the implications of insider transactions on their investment decisions.
James Patrick Kelly, the Executive Vice President, Chief Financial Officer, and Treasurer of Novavax, Inc. (NVAX), has executed a transaction involving the company's stock. The action took place on March 1, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Kelly after the transaction was not provided. This information is typically crucial for investors to assess the implications of insider transactions on their investment decisions.
Novavax, Inc.（NVAX）执行副总裁、首席财务官兼财务主管詹姆斯·帕特里克·凯利已经执行了一项涉及该公司股票的交易。该行动于 2024 年 3 月 1 日进行。但是，该公告没有透露交易的股票数量、股票的性质、交易价格或股票的总价值。此外，没有提供凯利在交易后持有的股票数量。这些信息对于投资者评估内幕交易对其投资决策的影响通常至关重要。
Novavax, Inc.（NVAX）执行副总裁、首席财务官兼财务主管詹姆斯·帕特里克·凯利已经执行了一项涉及该公司股票的交易。该行动于 2024 年 3 月 1 日进行。但是，该公告没有透露交易的股票数量、股票的性质、交易价格或股票的总价值。此外，没有提供凯利在交易后持有的股票数量。这些信息对于投资者评估内幕交易对其投资决策的影响通常至关重要。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息